- Filed
- Jun 5, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Jun 5, 2025 | 41.44B sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 45.58B sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 12.16B sh |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $25.62M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $26.69M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $25.62M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $26.69M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $19.03M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $2.99M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $39.03M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $23.22M |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$807.7K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$1.81M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$4.13M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.00 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $1.21M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$232.02K |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$1.53M |